Currently out of the existing stock ratings of Robert Wasserman, 83 are a BUY (86.46%), 13 are a HOLD (13.54%).

Robert Wasserman

Work Performance Price Targets & Ratings Chart

Analyst Robert Wasserman, currently employed at BENCHMARK, carries an average stock price target met ratio of 36.06% that have a potential upside of 20.26% achieved within 96 days.

Robert Wasserman’s has documented 169 price targets and ratings displayed on 16 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on TECH, Bio-Techne Corp at 05-Jun-2025.

Wall Street Analyst Robert Wasserman

Analyst best performing recommendations are on EBS (EMERGENT BIOSOLUTIONS).
The best stock recommendation documented was for EBS (EMERGENT BIOSOLUTIONS) at 4/11/2024. The price target of $5 was fulfilled within 32 days with a profit of $2.81 (128.31%) receiving and performance score of 40.1.

Average potential price target upside

of $18.79 (24.3%) on LGND (LIGAND PHARMACEUTICALS).
of $13.81 (12.24%) on ITGR (INTEGER HOLDINGS CORP).
of $12.9 (40.52%) on PRLB (PROTO LABS).

AERC Aeroclean Technologies LLC DHR Danaher PRLB Proto Labs EBS Emergent Biosolutions IPA Immunoprecise Antibodies Ltd LGND Ligand Pharmaceuticals ABCL Abcellera Biologics CDXS Codexis HALO Halozyme Therapeutics RGEN Repligen TECH Bio-Techne Corp BLFS BioLife Solutions ITGR Integer Holdings Corp NEPH Nephros ANEB Anebulo Pharmaceuticals OABI OmniAb

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Robert Wasserman (BENCHMARK)

Buy

$5.04 (257.14%)

2 years 11 months 18 days ago
(18-Aug-2022)

0/1 (0%)

$2.29 (48.62%)

Please subscribe to see the analyst performance score

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Robert Wasserman is most bullish on?

Potential upside of $31.49 has been obtained for ITGR (INTEGER HOLDINGS CORP)

Which stock is Robert Wasserman is most reserved on?

Potential downside of -$0 has been obtained for ABCL (ABCELLERA BIOLOGICS )

What Year was the first public recommendation made by Robert Wasserman?

On 2020